VS
stockvs
Go to ScreenerHub
MRK

MRK vs NVS

NVS

In the past 12 months, NVS returned +38% while MRK gained 22%.

MRK
MRK

Merck & Co., Inc.

$115.42
-5.1%(1M)
Market Cap285.4B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio15.97
ROE36.2%
P/B Ratio5.54
Dividend Yield2.8%
NVS
NVS

Novartis AG

$154.87
-6.8%(1M)
Market Cap299.4B
Healthcare
Drug Manufacturers - General
CH
P/E Ratio21.34
ROE32.8%
P/B Ratio6.48
Dividend Yield3.0%
Performance Comparison

Historical returns across multiple timeframes

NVS leads 5/8
MRK

MRK

Merck & Co., Inc.

+21.8%

1Y Return

NVS

NVS

Novartis AG

+38.0%

1Y Return

MRK
MRK
NVS
NVS

Short Term

1M-6M

MRK
+18.2%

Medium Term

YTD-1Y

NVS
+24.9%

Long Term

3Y-10Y

NVS
+113.5%

Valuation

Compare price multiples and valuation ratios

MRK: 4NVS: 1
MetricMRKNVSWinner
P/E Ratio

Price to earnings ratio

15.9721.34MRK
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

4.455.30MRK
P/B Ratio

Price to book ratio

5.546.48MRK
P/FCF Ratio

Price to free cash flow ratio

23.4217.78NVS
EV/EBITDA

Enterprise value to EBITDA

12.3414.15MRK
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

MRK: 6NVS: 0
MetricMRKNVSWinner
Gross Margin

Gross profit margin

81.5%75.7%MRK
Operating Margin

Operating profit margin

41.2%31.2%MRK
Net Margin

Net profit margin

28.1%24.9%MRK
ROE

Return on equity

36.2%32.8%MRK
ROA

Return on assets

13.3%12.1%MRK
ROIC

Return on invested capital

20.8%16.0%MRK

Growth

Compare revenue and earnings growth rates

MRK: 2NVS: 4
MetricMRKNVSWinner
Revenue Growth (YoY)

Year-over-year revenue growth

1.3%6.0%NVS
Revenue Growth (3Y)

3-year revenue CAGR

3.1%8.0%NVS
Revenue Growth (5Y)

5-year revenue CAGR

9.4%1.9%MRK
EPS Growth (YoY)

Year-over-year EPS growth

8.0%22.5%NVS
EPS Growth (3Y)

3-year EPS CAGR

8.4%31.4%NVS
EPS Growth (5Y)

5-year EPS CAGR

21.2%15.4%MRK

Balance Sheet & Risk

Compare financial stability and debt levels

MRK: 4NVS: 1
MetricMRKNVSWinner
Debt/Equity

Debt to equity ratio

0.960.80NVS
Current Ratio

Current assets to current liabilities

1.541.12MRK
Quick Ratio

Quick assets to current liabilities

1.300.89MRK
Interest Coverage

EBIT to interest expense

28.3415.13MRK
Beta

Stock volatility vs market

0.260.50MRK
Summary
MRK wins 3-1

Valuation

MRK

Profitability

MRK

Growth

NVS

Balance Sheet

MRK

MRK is more attractively valued. MRK shows stronger profitability. NVS demonstrates better growth. MRK has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into MRK and NVS with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/MRK/vs/NVS" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare MRK vs NVS on stockvs.app
</a>